Research suggests that Emsam doesn t cause sexual side effects in low doses. Exxua (gepirone): Exxua is the first and only approved antidepressant that selectively targets the serotonin 1a (5-HT1a) receptor. Unlike SSRIs, Exxua does not pose the risks of sexual side effects and has been approved by the FDA to treat MDD.
side effects. Like all medications, Exxua is not a perfect solution for everyone, so thorough discussions with healthcare providers to make
Side Effects Common Exxua side effects. The most common side effects of Exxua that happen in more than 5% of patients and at least twice the rate of placebo patients in
Studied in over 5,000 patients, EXXUA s unique mechanism of targeted single serotonin (5HT) 1a receptor agonism relieves depressive symptoms without significant side effects. EXXUA does not cause sexual dysfunction in depressed patients, a common side effect among most available antidepressants.
Research suggests that Emsam doesn t cause sexual side effects in low doses. Exxua (gepirone): Exxua is the first and only approved antidepressant that selectively targets the serotonin 1a (5-HT1a) receptor. Unlike SSRIs, Exxua does not pose the risks of sexual side effects and has been approved by the FDA to treat MDD.
Research suggests that Emsam doesn t cause sexual side effects in low doses. Exxua (gepirone): Exxua is the first and only approved antidepressant that selectively targets the serotonin 1a (5-HT1a) receptor. Unlike SSRIs, Exxua does not pose the risks of sexual side effects and has been approved by the FDA to treat MDD.
Common side effects (5% or more) occurring in those treated with Gepirone will be marketed as Exxua by Fabre-Kramer Pharmaceuticals.
side effects. EXXUA is expected to be available in pharmacies in early 2024. Lumanity provided strategic and tactical regulatory support to
side-effect language detailing risks of weight gain or sexual dysfunction. Exxua For Exxua's third go-around, Fabre-Kramer linked up
Comments